Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 12, 2021 - Sanofi announced the FDA approval of Fabrazyme (agalsidase beta), for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease.
Return to publications